These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39039342)

  • 1. Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway.
    Sun DL; Guo ZY; Liu WY; Zhang L; Zhang ZY; Hu YL; Li SF; Zhang MY; Zhang G; Wang JJ; Fang JA
    Chin J Integr Med; 2024 Jul; ():. PubMed ID: 39039342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects and molecular mechanism of exogenous L-carnitine on excessive endoplasmic reticulum stress-mediated hepatic pyroptosis in severely scald rats].
    Fan FX; Li PT; Xia ZG; Xie CQ; Xu JG; Xu Q
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Jul; 38(7):667-676. PubMed ID: 35899334
    [No Abstract]   [Full Text] [Related]  

  • 4. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
    He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
    J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
    BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of tacrolimus on podocytes in early diabetic nephropathy in rats.
    Peng T; Chang X; Wang J; Zhen J; Yang X; Hu Z
    Mol Med Rep; 2017 May; 15(5):3172-3178. PubMed ID: 28339051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
    Sun L; Ding M; Chen F; Zhu D; Xie X
    PeerJ; 2023; 11():e14826. PubMed ID: 36815984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of multi-glycosides of Tripterygium wilfordii on renal injury in diabetic kidney disease rats through NLRP3/caspase-1/GSDMD pyroptosis pathway].
    Song CD; Song D; Jia PP; Duan FY; Ding Y; Ren XQ; Zhai WS; Wang YX; Huang SL
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2639-2645. PubMed ID: 37282925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the glycogen synthase kinase 3β-hypoxia-inducible factor 1α pathway alleviates NLRP3-mediated pyroptosis induced by high glucose in renal tubular epithelial cells.
    Wan J; Jiang Z; Liu D; Pan S; Zhou S; Liu Z
    Exp Physiol; 2022 Dec; 107(12):1493-1506. PubMed ID: 36056793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect and mechanism of electroacupuncture of "Biao-Ben" acupoints combination for mitochondrial dysfunction in diabetic nephropathy rats].
    Chen J; Chen B; Liang FX; Wu S; Chen S; Han YL; Hu J; Chen ZQ; Wang KX; Zhang YL; Luo ZH; Gu XL; Zhou T
    Zhen Ci Yan Jiu; 2022 Sep; 47(9):759-68. PubMed ID: 36153450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway.
    Cui X; Li Y; Yuan S; Huang Y; Chen X; Han Y; Liu Z; Li Z; Xiao Y; Wang Y; Sun L; Liu H; Zhu X
    Biol Res; 2023 Feb; 56(1):5. PubMed ID: 36732854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geniposide alleviates diabetic nephropathy of mice through AMPK/SIRT1/NF-κB pathway.
    Li F; Chen Y; Li Y; Huang M; Zhao W
    Eur J Pharmacol; 2020 Nov; 886():173449. PubMed ID: 32758570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
    Guo M; Gao J; Jiang L; Dai Y
    Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C; Cheng T; Zhang B; Sun K; Lu K
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Curcumin alleviates nuclear factor-κB/NOD-like receptor protein 3 mediated renal injury caused by acute respiratory distress syndrome through reducing mitochondrial oxidative stress].
    Yang M; Tian H; Shen P; Xu L; Liu H; Zhu J; Wang Q; Shi Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Apr; 35(4):393-397. PubMed ID: 37308195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligustilide alleviates podocyte injury via suppressing the SIRT1/NF-κB signaling pathways in rats with diabetic nephropathy.
    Xu F; Ye Z; Tao S; Liu W; Su J; Fang X; Wang X
    Ann Transl Med; 2020 Sep; 8(18):1154. PubMed ID: 33241003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y; Ma Y; Xie D; Jiang H
    Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.